reference/26480241

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26480241

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1088
issn	0302-2838
issueIdentifier	6
pageRange	1083-1088
publicationName	European Urology
startingPage	1083
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8762af291d69cf5348b3c4749e5a8182 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1fb5be50ce019be957bdd05ffa9fe31a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1d5954b7bcbbfd192b587ee61f8351d6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_32f079e2bc761dd3a76e4264a061144b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_15efc6190f3be0fb3582a4f2b162ac6c
bibliographicCitation	Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator. European Urology. 2015 Dec;68(6):1083–8. doi: 10.1016/j.eururo.2015.03.023.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a8fee87dede95cb133b0cb919a0d082 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6a5215ed97dc1c9a78bd201c91389c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76f4b4c1af032775aaa1a1d2542aa2b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8503e1fbf599dd58d01d42e396fa2f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60970449f1c62beea7b56f7f42339831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c691e76cbfb956a78214f316a51ba24c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f51620f52af69ceab1689e8be39c5457 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17798f9c8edeae2d04b8471aae823b7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a042ed197207647b441744ecffa624ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cee0b543434fd92f9b950470942b889 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_190fc66b3ff06b119592418d48a5dd05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1d9f98064983c7c94f39f33aebddb57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8739581707b0d4f53593cdb6fa297090 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40df825619529e19b4f08715ae8fe517
date	201512
identifier	https://doi.org/10.1016/j.eururo.2015.03.023 https://pubmed.ncbi.nlm.nih.gov/25819722 https://pubmed.ncbi.nlm.nih.gov/PMC4583313
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3630 https://portal.issn.org/resource/ISSN/0302-2838
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D057832 http://id.nlm.nih.gov/mesh/D057285 http://id.nlm.nih.gov/mesh/D055088 http://id.nlm.nih.gov/mesh/D011471Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D035843 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D001706 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 55.